Perinatal consequences of maternal connective tissue diseases: a prospective study of 73 cases;Conséquences périnatales des connectivites maternelles : étude prospective de 73 cas

Archives de Pediatrie

Volumn 13, Issue 11, 2006, Pages 1386-1390

  Renaud, C ^a   de Montgolfier, I ^a   Vautier Brouzes, D ^a   Costedoat Chalumeau, N ^a   Lapillonne, A ^b   Gold, F ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Antibodies; antinuclear; Autoimmune diseases; complications; Heart block; immunology; Infant; Lupus erythematosus; newborn; Pregnancy complications; systemic

Indexed keywords

HYDROXYCHLOROQUINE; PREDNISONE; PREDNISONE ACETATE;

ARTICLE; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; FEMALE; FOLLOW UP; GESTATION PERIOD; HUMAN; INFANT; INTRAUTERINE INFECTION; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MATERNAL TREATMENT; MOTHER; NEWBORN; NEWBORN MORBIDITY; PR INTERVAL; PREGNANCY; PROSPECTIVE STUDY; QT INTERVAL; RASH; SMALL FOR DATE INFANT; THROMBOCYTOPENIA;

ADULT; CONNECTIVE TISSUE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROXYCHLOROQUINE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 33750185065     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.07.018     Document Type: Article

References (25)

1. Systemic lupus erythematosus in pregnancy. Editorial. Lancet 338 (1991) 87-88
2. Costedoat-Chalumeau N., Amoura Z., Villain E., et al. Prise en charge obstétricale des patientes à risque de « lupus néonatal ». J. Gynecol. Obstet. Biol. Reprod. (Paris) 35 (2006) 146-156
3. Costedoat-Chalumeau N., Amoura Z., Le Thi Huong D., et al. Lupus néonatal. Rev. Med. Interne 24 (2003) 659-671
4. Costedoat-Chalumeau N., Amoura Z., Duhaut P., et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 48 (2003) 3207-3211
5. Mamelle N., and Munoz F. Grandjean H pour le groupe de travail AUDIPOG. Croissance fœtale à partir de l'étude AUDIPOG. I. Établissement de courbes de référence. J. Gynecol. Obstet. Biol. Reprod. (Paris) 25 (1996) 61-70
6. Gordon C. Pregnancy and autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 18 (2004) 359-379
7. Rahman F.Z., Rahman J., Al-Suleiman S.A., et al. Pregnancy outcome in lupus nephropathy. Arch. Gynecol. Obstet. 271 (2005) 222-226
8. Cortes-Hernandez J., Ordi-Ros J., Paredes F., et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatol. 41 (2002) 643-650
9. Bykerk V.P., Sampalis J.S., and Esdaile J.M. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N. Engl. J. Med. 324 (1991) 150-154
10. Clark C.A., Spitzer K.A., Nadler J.N., et al. Preterm deliveries in women with systemic lupus erythematosus. J. Rheumatol. 30 (2003) 2127-2132
11. Wechsler B., Le Thi Huong D., and Piette J.C. Grossesse et lupus érythémateux systémique. Ann. Med. Interne (Paris) 150 (1999) 408-418
12. Buyon J.P., and Clancy R.M. Neonatal lupus syndromes. Curr. Opin. Rheumatol. 15 (2003) 535-541
13. Boh E.E. Neonatal lupus erythematosus. Clin. Dermatol. 22 (2004) 125-128
14. Buyon J.P., and Clancy R.M. Autoantibody-associated congenital heart block: TGFbeta and the road to scar. Autoimmun. Rev. 4 (2005) 1-7
15. Brucato A., Frassi M., Franceschini F., et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 44 (2001) 1832-1835
16. Buyon J.P., Hiebert R., Copel J., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrences rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 31 (1998) 1658-1666
17. Nield L.E., Silverman E.D., Taylor G.P., et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105 (2002) 843-848
18. Nield L.E., Silverman E.D., Smallhorn J.F., et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J. Am. Coll. Cardiol. 40 (2002) 796-802
19. Askanase A.D., Friedman D.M., Copel J., et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 11 (2002) 145-151
20. Cimaz R., Stramba-Badiale M., Brucato A., et al. QT interval prolongation in asymptomatic anti-SSA/Ro positive infants without congenital heart block. Arthritis Rheum. 43 (2000) 1049-1053
21. Costedoat-Chalumeau N., Amoura Z., Lupoglazoff J.M., et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 50 (2004) 3187-3194
22. Cimaz R., Spence D.L., Hornberger L., et al. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J. Pediatr. 142 (2003) 678-683
23. Neiman A.R., Lee L.A., Weston W.L., et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J. Pediatr. 137 (2000) 674-680
24. Lee L.A., Sokol R.J., and Buyon J.P. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 109 (2002) E11
25. Costedoat-Chalumeau N., Amoura Z., Aymard G., et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum. 46 (2002) 1123-1124